A Esquenazi

Summary

Affiliation: Albert Einstein Medical Center
Country: USA

Publications

  1. ncbi Influence of botulinum toxin type A treatment of elbow flexor spasticity on hemiparetic gait
    Alberto Esquenazi
    Gait and Motion Analysis Laboratory, MossRehab, Philadelphia, Pennsylvania, USA
    Am J Phys Med Rehabil 87:305-10; quiz 311, 329. 2008
  2. ncbi Muscle overactivity and movement dysfunction in the upper motoneuron syndrome
    Nathaniel H Mayer
    Department of Physical Medicine and Rehabilitation, Temple University Health Sciences Center, Broad Street, Philadelphia, PA 19140, USA
    Phys Med Rehabil Clin N Am 14:855-83, vii-viii. 2003
  3. ncbi Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity
    A Esquenazi
    Department of Physical Medicine and Rehabilitation, Gait and Motion Analysis Laboratory, MossRehab and Albert Einstein Medical Centre, Elkins Park, PA 19027, USA
    Eur J Neurol 13:27-34. 2006
  4. ncbi International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction
    A Esquenazi
    MossRehab Gait and Motion Analysis Laboratory, Department of PM and R, Elkins Park, PA 19027, USA
    Eur J Neurol 17:1-8. 2010
  5. ncbi Amputation rehabilitation and prosthetic restoration. From surgery to community reintegration
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, Moss Rehab Regional Amputee Rehabilitation Centre, Philadelphia, Pennsylvania, USA
    Disabil Rehabil 26:831-6. 2004
  6. ncbi Evaluation and management of spastic gait in patients with traumatic brain injury
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, MossRehab, Albert Einstein Medical Center, 1200 W Tabor Road, Philadelphia, PA 19141, USA
    J Head Trauma Rehabil 19:109-18. 2004
  7. ncbi Botulinum toxin for the management of adult patients with upper motor neuron syndrome
    Alberto Esquenazi
    MossRehab Gait and Motion Analysis Laboratory and Department of Rehabilitation Medicine, 60 Township Line Road, Elkins Park, PA 19027, USA
    Toxicon 54:634-8. 2009
  8. ncbi Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, Moss Rehab, Philadelphia, Pennsylvania 19141, USA
    Am J Phys Med Rehabil 83:S19-29. 2004
  9. ncbi Actual and perceived activity levels in polio survivors and older controls: a longitudinal study
    Mary G Klein
    Moss Rehabilitation Research Institute, Philadelphia, PA Thomas Jefferson University, Philadelphia 19141, USA
    Arch Phys Med Rehabil 89:297-303. 2008
  10. ncbi Musculoskeletal pain in polio survivors and strength-matched controls
    Mary G Klein
    Moss Rehabilitation Research Institute, Philadelphia, PA, USA
    Arch Phys Med Rehabil 85:1679-83. 2004

Detail Information

Publications18

  1. ncbi Influence of botulinum toxin type A treatment of elbow flexor spasticity on hemiparetic gait
    Alberto Esquenazi
    Gait and Motion Analysis Laboratory, MossRehab, Philadelphia, Pennsylvania, USA
    Am J Phys Med Rehabil 87:305-10; quiz 311, 329. 2008
    ..To assess whether walking velocity could be improved in patients with disorders related to upper-motor neuron syndrome (UMNS) by treating elbow flexor spasticity with botulinum toxin type A (BoNTA)...
  2. ncbi Muscle overactivity and movement dysfunction in the upper motoneuron syndrome
    Nathaniel H Mayer
    Department of Physical Medicine and Rehabilitation, Temple University Health Sciences Center, Broad Street, Philadelphia, PA 19140, USA
    Phys Med Rehabil Clin N Am 14:855-83, vii-viii. 2003
    ..The clinical impact of UMN on patients is broad and tends to limit functional capacity. The negative and positive signs lead to reduced mobility and limb usage...
  3. ncbi Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity
    A Esquenazi
    Department of Physical Medicine and Rehabilitation, Gait and Motion Analysis Laboratory, MossRehab and Albert Einstein Medical Centre, Elkins Park, PA 19027, USA
    Eur J Neurol 13:27-34. 2006
    ..Therefore, the clinical benefits of BoNT-A treatment outweigh the apparent high costs of this intervention, showing it to be a cost-effective treatment...
  4. ncbi International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction
    A Esquenazi
    MossRehab Gait and Motion Analysis Laboratory, Department of PM and R, Elkins Park, PA 19027, USA
    Eur J Neurol 17:1-8. 2010
    ..There is emergent evidence for the efficacy of BoNT to reduce focal tremor, to treat other types of pain including neuropathic pain and also to improve function following treatment of focal muscle over-activity...
  5. ncbi Amputation rehabilitation and prosthetic restoration. From surgery to community reintegration
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, Moss Rehab Regional Amputee Rehabilitation Centre, Philadelphia, Pennsylvania, USA
    Disabil Rehabil 26:831-6. 2004
    ..The purpose of this review is to summarize the literature related to the advances that have taken place in the management and rehabilitation care of limb amputation...
  6. ncbi Evaluation and management of spastic gait in patients with traumatic brain injury
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, MossRehab, Albert Einstein Medical Center, 1200 W Tabor Road, Philadelphia, PA 19141, USA
    J Head Trauma Rehabil 19:109-18. 2004
    ..The treatment strategies based on the algorithm included in this article were focused on the use of chemodenervation of targeted muscles, neuro-orthopedic surgery, and other therapeutic strategies...
  7. ncbi Botulinum toxin for the management of adult patients with upper motor neuron syndrome
    Alberto Esquenazi
    MossRehab Gait and Motion Analysis Laboratory and Department of Rehabilitation Medicine, 60 Township Line Road, Elkins Park, PA 19027, USA
    Toxicon 54:634-8. 2009
    ..A common sense approach would be to introduce BoNT treatment as early as possible, in order to prevent further complications including contractures...
  8. ncbi Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, Moss Rehab, Philadelphia, Pennsylvania 19141, USA
    Am J Phys Med Rehabil 83:S19-29. 2004
  9. ncbi Actual and perceived activity levels in polio survivors and older controls: a longitudinal study
    Mary G Klein
    Moss Rehabilitation Research Institute, Philadelphia, PA Thomas Jefferson University, Philadelphia 19141, USA
    Arch Phys Med Rehabil 89:297-303. 2008
    ..To examine factors associated with daily step activity, perceived activity, maximum walking speed, and walking speed reserve over time in polio survivors and older adults with no history of polio...
  10. ncbi Musculoskeletal pain in polio survivors and strength-matched controls
    Mary G Klein
    Moss Rehabilitation Research Institute, Philadelphia, PA, USA
    Arch Phys Med Rehabil 85:1679-83. 2004
    ..To determine whether a significant difference exists between musculoskeletal symptoms of polio survivors and those of older adults with no history of polio, and to determine if activity level and strength predict pain in either group...
  11. ncbi Botulinum neurotoxin in muscle overactivity
    Alberto Esquenazi
    Department of Physical Medicine and Rehabilitation, MossRehab and Albert Einstein Medical Center, Elkins Park, PA 19027, USA
    J Head Trauma Rehabil 20:563-7. 2005
  12. ncbi Botulinum toxin for the management of muscle overactivity and spasticity after stroke
    A Esquenazi
    MossRehab Gait and Motion Analysis Laboratory, 1200 West Tabor Road, Philadelphia, PA 19141, USA
    Curr Atheroscler Rep 3:295-8. 2001
    ..Smaller muscles are readily accessible for injection and require smaller amounts of toxin...
  13. ncbi The influence of dynamic polyelectromyography in formulating a surgical plan in treatment of spastic elbow flexion deformity
    Mary Ann Keenan
    Institute for Mobility Evaluation and Treatment, MossRehab Hospital, Albert Einstein Medical Center, Philadelphia, PA, USA
    Arch Phys Med Rehabil 84:291-6. 2003
    ..To determine the influence of motor-control analysis with dynamic electromyography on surgical planning in patients with spastic elbow flexion deformity...
  14. ncbi The impact of instrumented gait analysis on surgical planning: treatment of spastic equinovarus deformity of the foot and ankle
    David A Fuller
    The Graduate Hospital, Philadelphia, PA 19146, USA
    Foot Ankle Int 23:738-43. 2002
    ..Rather, a muscle specific approach that identifies the deforming forces will produce the best outcomes when treating the spastic equinovarus deformity...
  15. ncbi The effect of an ankle-foot orthosis on temporal spatial parameters and asymmetry of gait in hemiparetic patients
    Alberto Esquenazi
    Gait and Motion Analysis Laboratory, MossRehab, Elkins Park, PA 19027, USA
    PM R 1:1014-8. 2009
    ..To investigate the effect of an ankle-foot orthosis (AFO) on certain walking parameters in patients with hemiplegia...
  16. ncbi Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot
    Matteo Cioni
    Department of Experimental and Clinical Pharmacology, Medical School, University of Catania, Catania, Italy
    Am J Phys Med Rehabil 85:600-6. 2006
    ..No change was evident in step length or walking velocity for this patient population...
  17. ncbi Temporospatial parameters of gait after obturator neurolysis in patients with spasticity
    Demet Ofluoglu
    Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey
    Am J Phys Med Rehabil 82:832-6. 2003
    ..In the studied population, improvement was found in the width of the base of support without immediate change in walking velocity or step length...
  18. ncbi Evidence-based review of patient-reported outcomes with botulinum toxin type A
    Joseph Jankovic
    Parkinson s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Neuropharmacol 27:234-44. 2004
    ..These studies provide evidence that BTX-A exerts meaningful benefits on the quality of life of patients treated with this biologic agent...